TABLE 1.
Colocalization of WT and mutant MARCH8, viral glycoproteins, and cellular markers
| Viral GPa |
r valueb |
|||||
|---|---|---|---|---|---|---|
| MARCH8 | MARCH8-CS | +MARCH8 |
+MARCH8-CS |
|||
| Golgi-transferasec | LAMP-1 | Golgi-transferase | LAMP-1 | |||
| VSV-G | 0.92 ± 0.08 | 0.82 ± 0.13 | 0.91 ± 0.03 | 0.89 ± 0.06 | 0.88 ± 0.01 | 0.16 ± 0.01 |
| VSV-G Tailless | 0.85 ± 0.11 | 0.80 ± 0.09 | 0.74 ± 0.14 | 0.31 ± 0.01 | 0.79 ± 0.15 | 0.18 ± 0.15 |
| VSV-G K-to-R | 0.83 ± 0.01 | 0.79 ± 0.01 | 0.90 ± 0.02 | 0.32 ± 0.04 | 0.85 ± 0.04 | 0.14 ± 0.04 |
| HIV-1 Env | 0.89 ± 0.13 | 0.79 ± 0.05 | 0.86 ± 0.07 | 0.79 ± 0.04 | 0.78 ± 0.02 | 0.18 ± 0.12 |
| HIV-1 EnvCTdel144 | 0.87 ± 0.12 | 0.79 ± 0.02 | 0.79 ± 0.16 | 0.76 ± 0.04 | 0.79 ± 0.11 | 0.19 ± 0.02 |
| EboV-GP | 0.78 ± 0.06 | 0.73 ± 0.12 | 0.87 ± 0.11 | 0.67 ± 0.06 | 0.82 ± 0.08 | 0.12 ± 0.01 |
| EboV-GP Tailless | 0.82 ± 0.08 | 0.71 ± 0.15 | 0.81 ± 0.07 | 0.61 ± 0.21 | 0.79 ± 0.16 | 0.15 ± 0.13 |
| SARS-CoV-2 S-FL | 0.81 ± 0.01 | 0.72 ± 0.01 | 0.68 ± 0.13 | 0.65 ± 0.16 | 0.67 ± 0.08 | 0.20 ± 0.05 |
| SARS-CoV-2 S-FL-K-to-R | 0.86 ± 0.11 | 0.77 ± 0.05 | 0.67 ± 0.14 | 0.67 ± 0.21 | 0.69 ± 0.12 | 0.18 ± 0.06 |
| SARS-CoV-2 S-Trun | 0.89 ± 0.12 | 0.83 ± 0.03 | 0.79 ± 0.08 | 0.85 ± 0.08 | 0.78 ± 0.06 | 0.22 ± 0.14 |
| SARS-CoV-2 S-Trun K-to-R | 0.92 ± 0.06 | 0.86 ± 0.13 | 0.81 ± 0.1 | 0.81 ± 0.16 | 0.80 ± 0.21 | 0.14 ± 0.01 |
Viral glycoprotein.
Pearson correlation coefficient (r) values, means ± standard deviation (SD) using 50 cells per experimental condition. The r values indicate colocalization between MARCH8 and intracellular viral glycoprotein (first two columns), intracellular viral glycoprotein and cellular markers in the presence of WT MARCH8 (two middle columns), and intracellular viral glycoprotein and cellular markers in the presence of MARCH8-CS (right two columns).
Golgi-transferase = beta-1,4-galatosyltransferase.